可吸入的干细胞衍生的人造纳米纤维用于有针对性的siRNA输送,以有效地缓解喘症状
Shihan Chen1,2, Ruyi Lin1, Yuhuan Kong1
1School of Pharmacy, Zhejiang University, Hangzhou 310058, China.
Asian journal of pharmaceutical sciences
|March 11, 2026
概括
这项研究引入了新的纳米纤维,用于将小干扰RNA (siRNA) 传递给呼吸道细胞,有效地减少喘症状和炎症. 这为喘和其他呼吸系统疾病提供了一个有前途的新吸入疗法.
科学领域:
- 生物医学工程 生物医学工程
- 呼吸系统医学 呼吸系统医学
- 纳米技术纳米技术
背景情况:
- 由于缺乏向分子途径的治疗方法,喘管理具有挑战性.
- 目前的治疗方法提供广泛的免疫抑制和支气管扩张,而不是疾病特定的解决方案.
- 将小干扰RNA (siRNA) 等基因疗法有效地输送到气道上皮细胞 (AEC) 是喘治疗的一个主要障碍.
研究的目的:
- 开发一个高效的,可吸入的siRNA输送系统,针对喘治疗的AEC.
- 从介质细胞干细胞创建新的纳米纤维,用于向siRNA传递.
- 为了研究和优化有效的 nebulized nanovesicle 基siRNA 交付的参数.
主要方法:
- 人工准备的纳米纤维是使用中细胞干细胞的设计挤出过程来创建的.
- 坐标测试用于优化诸如挤出周期,孔径大小和离心力等参数,用于吸入输送.
- 在卵胺诱导的喘模型中,纳米纤维被测试了它们向AECs输送胸膜 stromal lymphopoietin向siRNA的能力.
主要成果:
- 优化的纳米纤维证明了siRNA在AEC中有效的输送.
- 治疗显著抑制了与喘相关的炎症途径和杯状细胞增生.
- 在动物模型中观察到明显的喘症状抑制.
结论:
- 一种基于纳米微粒的新型雾化载体使siRNA的有效局部吸入传递成为可能.
- 这个平台对治疗喘和潜在的其他呼吸系统疾病有很大的希望.
- 该研究提供了一种针对呼吸道疾病的基因干预的新治疗交付策略.
更多相关视频
15:55Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
Published on: June 21, 2013
11.2K
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
41.7K
相关概念视频
02:30siRNA - Small Interfering RNAs
18.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.9K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.1K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K
01:20Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K